BUSINESSNY POST
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
AstraZeneca is in talks with Bristol Myers Squibb to finalize a $400 billion megadeal, which would create one of the world's largest pharmaceutical groups with a combined value of nearly $400 billion.
Mentioned
Related Signal
Adjacent reporting
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
- AstraZeneca said to have explored Bristol Myers merger
- AstraZeneca Said to Have Explored Bristol Myers Merger
- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
- STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
- STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more